Smoking remains the single most preventable cause of morbidity and mortality in the United States, accounting for approximately half a million deaths every year. The current study will investigate the efficacy and mechanisms of change of a novel smoking cessation intervention. The current study will thus provide essential information regarding a treatment that has the potential to enhance the efficacy of existing smoking cessation interventions, thereby having a beneficial impact on the public health of the United States.
at least 18 years of age
smoke at least 5 cigarettes per day
Expired breath carbon monoxide (CO) reading of at least five parts per million
report the intention to quit
inability to speak English
presence of a condition that contraindicates use of the nicotine patch
presence of conditions that might interfere with compliance with the protocol or greatly complicate treatment
any acutely life-threatening disease
University of Alabama at Birmingham
Lead sponsor
National Institute on Drug Abuse (NIDA)
Collaborator